- Cyclacel Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
- VANC Pharmaceuticals Announces Non Brokered Private Placement
- Lentigen Technology Inc., a Miltenyi Biotec Company, Acquires University of Maryland, Baltimore CAR-T Cell Start-Up, Living Pharma, Inc.
- Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi
- Cyclacel Announces Pricing of $13.2 Million Underwritten Public Offering
- Animal Healthcare Market worth over $36 billion by 2024: Global Market Insights, Inc.
- Organovo Announces Release Date for Fiscal First-Quarter 2018 Financial Results
- RedHill Biopharma to Host Second Quarter 2017 Financial Results Conference Call on July 25, 2017
- Phase 1 Data for Flotetuzumab, MacroGenics’ CD123 x CD3 DART® Molecule, Accepted for Oral Presentation at ESMO Congress 2017
- Barite Market to cross $4.1bn by 2024: Global Market Insights, Inc.
|"INO announced the publication of data from a preclinical study of the company's plasmid DNA-encoded monoclonal antibody to protect against influenza infections."|
|"Early completion of enrollment for PERSIST, at 12% higher enrollment than targeted, has positive implications for DRRX's Posimir."|